Skip to main content

Table 3 PDP offices in endemic countries

From: Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making

PDP

Offices in endemic countries

Drugs for Neglected Disease Initiative (DNDi)

Kenya, Brazil, Democratic Republic of the Congo, India, Malaysia, where it may be as small as a 1-person office

PATH Malaria Vaccine Initiative (MVI)

PATH office in Kenya with dedicated MVI program staff, plus PATH offices that can be called upon such as in Senegal, Ghana, Ethiopia, Uganda, Tanzania, Zambia, and South Africa

Medicines for Malaria Venture (MMV)

Uganda, initially for pilot of AMFm (Affordable Medicines Facility - malaria), now for regional interactions on guideline revisions

Institute for One World Health (iOWH)

India

Global Alliance for TB Drug Development (TB Alliance)

South Africa - focused on clinical trial conduct rather than access

Foundation for Innovative New Diagnostics (FIND)

India, Uganda

International AIDS Vaccine Initiative (IAVI)

India, Kenya, South Africa

Aeras Global TB Vaccine Foundation (Aeras)

South Africa

International Partnership for Microbicides (IPM)

South Africa